Results 171 to 180 of about 1,140,223 (331)

The impact of the new WHO classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma. [PDF]

open access: yesNephrol Dial Transplant
Degenhardt J   +19 more
europepmc   +1 more source

SIDE EFFECTS OF INTERFERON-α (INF-α) THERAPY FOR RENAL CELL CARCINOMA

open access: bronze, 1989
Yoshihiro Totsuka   +5 more
openalex   +2 more sources

STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao   +20 more
wiley   +1 more source

EAU guidelines on renal cell carcinoma: 2014 update.

open access: yesEuropean Urology, 2010
B. Ljungberg   +14 more
semanticscholar   +1 more source

Determinants of late metastases in renal cell carcinoma. [PDF]

open access: yesJ Natl Cancer Inst
Kapur P   +16 more
europepmc   +1 more source

SF3A3 Drives Tumorigenesis in Endometrial Cancer by Enhancing c‐FOS Expression and Represents a Potential Therapeutic Target

open access: yesAdvanced Science, EarlyView.
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu   +13 more
wiley   +1 more source

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

open access: yesNature Network Boston, 2020
R. Motzer   +22 more
semanticscholar   +1 more source

PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma

open access: yesAdvanced Science, EarlyView.
Inducing ferroptosis is a promising strategy for combating tumor resistance. Upregulated PIP5K1A competes with NRF2 for KEAP1 binding, which decreases the ubiquitination degradation of NRF2 and promotes its nuclear translocation, thereby suppressing ferroptosis, and ultimately driving hepatocellular carcinoma (HCC) tumorigeneses and sorafenib ...
Mengzhou Guo   +9 more
wiley   +1 more source

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

open access: yesNature Reviews Nephrology, 2020
E. Jonasch, C. Walker, W. Rathmell
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy